Peter Attia· MD
the pharmacocinetics are as much as you and we mimicked it exactly in our lab. You go up you have an initial peak and then like an hour or two later you have a second peak from the 13 butane dial and so it's it's a nice molecule.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the pharmacocinetics are as much as you and we mimicked it exactly in our lab. You go up you have an initial peak and then like an hour or two later you have a second peak from the 13 butane dial and so it's it's a nice molecule.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.